Harvey J A, Fechner R E, Moore M M
Department of Radiology, University of Virginia, Charlottesville 22908, USA.
Radiology. 2000 Mar;214(3):883-9. doi: 10.1148/radiology.214.3.r00mr27883.
To assess if infiltrating lobular carcinoma (ILC) is associated with an ipsilateral mammographic decrease in breast size.
Mammographic change in size was evaluated by measuring the distance from the nipple to the pectoralis major muscle on the mediolateral oblique view of the diagnostic mammogram and on a preceding mammogram in 30 patients with ILC. Clinical, mammographic, and histopathologic findings were retrospectively reviewed.
Five patients (17%) had an ipsilateral decrease in mammographic size. No patients noticed a physical decrease in breast size. Patients with an ipsilateral decrease in mammographic size most commonly had breast thickening at examination (four of five patients [80%], P < .001) and either a focal asymmetry density (three of five patients [60%]) or architectural distortion (one of five patients [20%]) at mammography; those patients with no change in size most commonly had a palpable mass (six of 25 patients [24%]) or normal findings (19 of 25 patients [76%]) and a mass (13 of 25 patients [52%]) at mammography. The mean tumor size was 66 mm for those with an ipsilateral size decrease and 16 mm for those with no size decrease (P < .001). At histologic analysis, tumors associated with an ipsilateral decrease in mammographic size had more diffuse involvement of the breast, and discrete masses were not seen.
An apparent decrease in mammographic size may help identify cases of ILC, especially when associated with thickening at clinical examination and focal asymmetric density at mammography.
评估浸润性小叶癌(ILC)是否与同侧乳房钼靶检查显示的乳房大小减小有关。
通过在诊断性乳房钼靶的内外斜位视图上以及在之前的乳房钼靶上测量乳头到胸大肌的距离,评估30例浸润性小叶癌患者乳房大小的钼靶变化。对临床、钼靶和组织病理学检查结果进行回顾性分析。
5例患者(17%)同侧乳房钼靶检查显示大小减小。没有患者注意到乳房实际大小减小。同侧乳房钼靶检查显示大小减小的患者在检查时最常见的表现是乳房增厚(5例患者中有4例[80%],P <.001),在钼靶检查中表现为局灶性不对称密度(5例患者中有3例[60%])或结构扭曲(5例患者中有1例[20%]);那些乳房大小无变化的患者在检查时最常见的表现是可触及肿块(25例患者中有6例[24%])或正常表现(25例患者中有19例[76%]),在钼靶检查中有肿块(25例患者中有13例[52%])。同侧乳房大小减小的患者平均肿瘤大小为66 mm,无大小减小的患者平均肿瘤大小为16 mm(P <.001)。在组织学分析中,与同侧乳房钼靶检查显示大小减小相关的肿瘤乳房受累更广泛,未见离散肿块。
钼靶检查显示乳房大小明显减小可能有助于识别浸润性小叶癌病例,特别是当与临床检查中的增厚以及钼靶检查中的局灶性不对称密度相关时。